What does it mean to test positive for hepatitis B surface antigen (HBsAg) and hepatitis B core antibody (anti-HBc)?

May 24, 2022 Source: Cainiu Health
Dr. Jiang Weimin
Introduction
A positive result for hepatitis B surface antibody (anti-HBs) and core antibody (anti-HBc)—commonly referred to as “patterns 4 and 5 positive” in the five-item hepatitis B serological panel—is a relatively common serological profile indicating recovery following hepatitis B virus (HBV) infection. This pattern is frequently observed clinically and suggests prior HBV infection with effective immune clearance by the host. In such cases, hepatitis B surface antigen (HBsAg) is negative. If anti-HBs subsequently becomes positive, it signifies the development of protective immunity against HBV, rendering the individual less susceptible to reinfection.

In daily life, we sometimes visit hospitals to collect test reports and may find the report states “HBV markers 4 and 5 positive.” What does “HBV markers 4 and 5 positive” mean?

What does “HBV markers 4 and 5 positive” mean?

“HBV markers 4 and 5 positive” refers to positivity for hepatitis B e antibody (HBeAb) and hepatitis B core antibody (HBcAb) among the five standard hepatitis B serological markers. This pattern commonly reflects a recovery phase following hepatitis B virus (HBV) infection. It is clinically common to observe positivity for markers 4 and 5 alone, indicating prior HBV infection coupled with effective host immune clearance—typically accompanied by negativity for hepatitis B surface antigen (HBsAg).

If hepatitis B surface antibody (HBsAb) later becomes positive, immunity against HBV develops, significantly reducing susceptibility to reinfection. Hepatitis B primarily affects individuals with acute or chronic hepatitis B and asymptomatic HBV carriers. Acutely infected patients are infectious during the late incubation period and acute phase, but this infectious period lasts no longer than six months. In contrast, chronically infected patients and asymptomatic carriers constitute the most significant reservoirs of infection; their infectivity correlates directly with the level of HBV replication and the concentration of HBV DNA in bodily fluids. Major transmission routes include: (1) mother-to-child transmission—via intrauterine infection, perinatal exposure, or postnatal contact; intrauterine infection occurs transplacentally and accounts for approximately 5% of infants born to HBsAg-positive mothers, possibly associated with minor placental abruption during pregnancy; (2) percutaneous or mucosal exposure to infectious blood or body fluids—particularly high-risk due to the high HBV load in blood; and (3) other routes such as sharing razors or syringes.


We hope this explanation has been helpful to you!